The report on “Glaucoma Surgery Devices Medical Devices Pipeline Assessment, 2016" provides an overview of Glaucoma Surgery Devices currently in pipeline stage.

PUNE, INDIA, April 18, 2016 /EINPresswire.com/ -- The report “Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016" provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Glaucoma Surgery Devices pipeline products.

Access a Report Copy @ https://www.wiseguyreports.com/reports/glaucoma-surgery-devices-medical-devices-pipeline-assessment-2016 .

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Glaucoma Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Glaucoma Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Purchase a 1-User License Copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=403218 .

Major Points in Table of Content

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9
2 Introduction 10
2.1 Glaucoma Surgery Devices Overview 10
3 Products under Development 11
3.1 Glaucoma Surgery Devices - Pipeline Products by Stage of Development 11
3.2 Glaucoma Surgery Devices - Pipeline Products by Segment 12
3.3 Glaucoma Surgery Devices - Pipeline Products by Territory 13
3.4 Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 14
3.5 Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 15
3.6 Glaucoma Surgery Devices - Ongoing Clinical Trials 16
4 Glaucoma Surgery Devices - Pipeline Products under Development by Companies 17
4.1 Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development 17
4.2 Glaucoma Surgery Devices - Pipeline Products by Stage of Development 19
5 Glaucoma Surgery Devices Companies and Product Overview 21
5.1 Allergan Plc Company Overview 21
5.1.1 Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 21
5.2 Anteis S.A. Company Overview 25
5.2.1 Anteis S.A. Pipeline Products & Ongoing Clinical Trials Overview 25
5.3 Assenti, LLC Company Overview 26
5.3.1 Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Camras Vision Company Overview 27
5.4.1 Camras Vision Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Ellex Medical Lasers Limited Company Overview 28
5.5.1 Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Eye Sonix Company Overview 29
5.6.1 Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Galaxy Ophthalmics Inc Company Overview 30
5.7.1 Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Geuder AG Company Overview 31
5.8.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 Glaukos Corporation Company Overview 33
5.9.1 Glaukos Corporation Pipeline Products & Ongoing Clinical Trials Overview 33
5.10 InnFocus LLC Company Overview 41
5.10.1 InnFocus LLC Pipeline Products & Ongoing Clinical Trials Overview 41
5.11 IPI Singapore Company Overview 44
5.11.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 44
5.12 iSTAR Medical Company Overview 45
5.12.1 iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview 45
5.13 Ivantis, Inc. Company Overview 47
5.13.1 Ivantis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.14 Konan Medical Inc. Company Overview 51
5.15 Kytogenics Pharmaceuticals, Inc. Company Overview 54
5.16 Massachusetts Eye and Ear Infirmary Company Overview 55
5.17 Medtronic plc Company Overview 56
5.18 Meir Medical Center Company Overview 58
5.19 MicroOptx, Inc. Company Overview 59
5.20 Ocular Therapeutix, Inc. Company Overview 60
5.21 Oculox Technology Sagl Company Overview 62
5.22 Ocumatrx Company Overview 63
5.23 OcuTherix, Inc. Company Overview 64
5.24 OPKO Health, Inc. Company Overview 65
5.25 OptoLight Vision Technology Company Overview 67
5.26 PolyActiva Pty Ltd Company Overview 69
5.27 Queen's University Company Overview 70
5.28 Refocus Group, Inc. Company Overview 71
5.29 SOLX, Inc. Company Overview 73
5.30 Tel Aviv University Company Overview 76
5.31 TonoGuard Ltd. Company Overview 78
5.32 Transcend Medical, Inc. Company Overview 79
5.33 University of Rostock Company Overview 82
5.34 ViSci Ltd. Company Overview 83
5.35 Westhouse Medical Services Plc Company Overview 84
6 Glaucoma Surgery Devices- Recent Developments 85
7 Appendix 111

Inquire for more information @ https://www.wiseguyreports.com/enquiry/glaucoma-surgery-devices-medical-devices-pipeline-assessment-2016 .

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
16468459349
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.